A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009.
About This Bill
Committee
Latest Action · April 11, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.